Home  /  Resources  /  Compliance
Compliance

How to Market Semaglutide & GLP-1 Without Getting Your Ads Shut Down (2026 Guide)

Owners are right to be nervous. In March 2026 alone the FDA issued 30 warning letters over misleading compounded GLP-1 ads. Here's how to market medical weight-loss in a way that keeps your accounts open and your clinic out of trouble.

What changed: the shortage resolved

The FDA marked the semaglutide shortage 'resolved' in February 2025, ending the window where pharmacies could routinely compound copies of GLP-1 drugs. That single change reshaped what you can legally say and sell — and a lot of med spa ads and websites are now out of date and exposed.

What's still legal in 2026

Plenty. Branded GLP-1 prescribing, narrow 503B outsourcing-facility supply, and patient-specific 503A compounding when there's documented clinical need all remain viable. Medical weight-loss is absolutely still a business — you just have to message it correctly.

LegitScript is now non-negotiable

Google requires LegitScript certification before it will run most weight-loss and prescription-adjacent ads. As of 2026, Visa and Mastercard also require it for GLP-1 merchants — without it, most acquiring banks decline you. If you're running GLP-1 ads without certification, you're one review away from a shutdown.

The claims that get you flagged

Don't call compounded GLP-1s 'generic,' 'equivalent,' or claim identical outcomes to the branded drug — that's exactly what the FDA and the National Advertising Division (backed by Eli Lilly and Novo Nordisk) are targeting. And per FTC rules, testimonials must reflect typical results — never feature only your best outlier.

How to stay compliant AND booked

Get LegitScript certified, keep your ad and website claims current with FDA positioning, sell the supervised program and the experience rather than 'cheap semaglutide,' and document everything. Done right, compliance is a competitive moat — most of your local competitors don't track any of this, and their accounts are the ones getting flagged.

Quick Answers

Do I need LegitScript certification to advertise semaglutide?

Yes. As of 2026 Google requires it to run most GLP-1 ads, and Visa/Mastercard require it for GLP-1 merchants. Without certification your ads get flagged and your payment processing can be declined.

Is it still legal to offer GLP-1 weight-loss in 2026?

Yes — branded GLP-1 prescribing, 503B supply, and patient-specific 503A compounding remain legal. The compliance risk is mostly in how it's advertised, not in offering it.

Keep Reading

Want this done for you?

We fill one med spa's calendar per city with 30+ qualified consults a month — guaranteed in 90 days or we work free. Start with the free guide, or apply to see if your city's open.